BACKGROUND: This study describes the incidence, clinical and demographic characteristics, and spectrum of chronic kidney disease (CKD) in youths with perinatal HIV-1 infection. METHODS: Retrospective analysis between May 1993 and December 2006 of subjects with renal disease followed in the Pediatric AIDS Clinical Trials Group 219/219C multicenter study examining the long-term consequences of perinatal HIV infection. Diagnosis confirmation was made utilizing a questionnaire mailed to research sites. Participants with CKD of other etiology than HIV were excluded. Outcome measures were biopsy-diagnosed CKD and, in the absence of biopsy, HIV-associated nephropathy (HIVAN) using established clinical criteria. RESULTS: Questionnaires on 191 out of 2,102 participants identified 27 cases of CKD: 14 biopsy-diagnosed and 6 clinical cases of HIVAN, and 7 biopsy-diagnosed cases of immune complex-mediated kidney disease (lupus-like nephritis, 3; IgA nephropathy, 2; membranous nephropathy, 2). Incidence rates for CKD associated with HIV in pre-highly active antiretroviral therapy (HAART) (1993-1997) and HAART (1998-2002, 2003-2006) eras were 0.43, 2.84, and 2.79 events per 1,000 person years respectively. In multivariate analysis, black race and viral load ≥100,000 copies/mL (rate ratios 3.28 and 5.05, p ≤ 0.02) were associated with CKD. CONCLUSIONS: A variety of immune complex-mediated glomerulonephritides and HIVAN occurs in this population. Black race and uncontrolled viral replication are risk factors for CKD associated with HIV.
BACKGROUND: This study describes the incidence, clinical and demographic characteristics, and spectrum of chronic kidney disease (CKD) in youths with perinatal HIV-1 infection. METHODS: Retrospective analysis between May 1993 and December 2006 of subjects with renal disease followed in the Pediatric AIDS Clinical Trials Group 219/219C multicenter study examining the long-term consequences of perinatal HIV infection. Diagnosis confirmation was made utilizing a questionnaire mailed to research sites. Participants with CKD of other etiology than HIV were excluded. Outcome measures were biopsy-diagnosed CKD and, in the absence of biopsy, HIV-associated nephropathy (HIVAN) using established clinical criteria. RESULTS: Questionnaires on 191 out of 2,102 participants identified 27 cases of CKD: 14 biopsy-diagnosed and 6 clinical cases of HIVAN, and 7 biopsy-diagnosed cases of immune complex-mediated kidney disease (lupus-like nephritis, 3; IgAnephropathy, 2; membranous nephropathy, 2). Incidence rates for CKD associated with HIV in pre-highly active antiretroviral therapy (HAART) (1993-1997) and HAART (1998-2002, 2003-2006) eras were 0.43, 2.84, and 2.79 events per 1,000 person years respectively. In multivariate analysis, black race and viral load ≥100,000 copies/mL (rate ratios 3.28 and 5.05, p ≤ 0.02) were associated with CKD. CONCLUSIONS: A variety of immune complex-mediated glomerulonephritides and HIVAN occurs in this population. Black race and uncontrolled viral replication are risk factors for CKD associated with HIV.
Authors: Bouchra Zerhouni-Layachi; Mohammad Husain; Michael J Ross; Daniele Marras; Masaaki Sunamoto; Xinyan Liu; Paul E Klotman; Mary E Klotman Journal: AIDS Date: 2006-02-28 Impact factor: 4.177
Authors: Michelle Estrella; Derek M Fine; Joel E Gallant; M Hafizur Rahman; Nagapradeep Nagajothi; Lorraine C Racusen; Paul J Scheel; Mohamed G Atta Journal: Clin Infect Dis Date: 2006-06-20 Impact factor: 9.079
Authors: Susan Brogly; Paige Williams; George R Seage; James M Oleske; Russell Van Dyke; Kenneth McIntosh Journal: JAMA Date: 2005-05-11 Impact factor: 56.272
Authors: Michael J Ross; Cheng Fan; Michael D Ross; Te-Huatearina Chu; Yueyue Shi; Lewis Kaufman; Weijia Zhang; Mary E Klotman; Paul E Klotman Journal: J Acquir Immune Defic Syndr Date: 2006-05 Impact factor: 3.731
Authors: D Nochy; D Glotz; P Dosquet; A Pruna; C Guettier; L Weiss; N Hinglais; J M Idatte; J P Méry; M Kazatchkine Journal: Nephrol Dial Transplant Date: 1993 Impact factor: 5.992
Authors: Charles D Mitchell; Miriam C Chernoff; George R Seage; Murli U Purswani; Hans M L Spiegel; Gaston Zilleruelo; Carolyn Abitbol; Barbara Heckman; Christopher B Ponce; James M Oleske Journal: Pediatr Nephrol Date: 2014-08-24 Impact factor: 3.714
Authors: Brian Kirmse; Charlotte Hobbs; Lisa Aaron; Grace Montepiedra; Marshall Summar; Paige L Williams; Caitlin J Smith; Russell Van Dyke; Chunli Yu; Kelli K Ryckman; William Borkowsky Journal: Pediatr Infect Dis J Date: 2022-07-13 Impact factor: 3.806
Authors: Murli U Purswani; Kunjal Patel; Cheryl A Winkler; Stephen A Spector; Rohan Hazra; George R Seage; Lynne Mofenson; Brad Karalius; Gwendolyn B Scott; Russell B Van Dyke; Jeffrey B Kopp Journal: J Acquir Immune Defic Syndr Date: 2016-09-01 Impact factor: 3.731